Mark Anderson

Mark Anderson has extensive work experience in the field of diabetes research and clinical immunology. Mark is currently the Director of the UCSF Diabetes Center and holds the Robert B. Friend and Michelle M. Friend Endowed Chair in Diabetes Research. Mark has been in this role since September 2003.

In addition to their position as Director, they have also served as the Interim Director of the UCSF Diabetes Center from December 2020 to March 2022. Furthermore, they were previously the Director of the Medical Scientist Training (MD/PhD) Program from September 2012 to June 2021.

Mark Anderson has also held prominent roles in other organizations, including serving as the Deputy Director of the Immune Tolerance Network since February 2021 and as the President of the Federation of Clinical Immunology Societies (FOCIS) since August 2020.

Before joining UCSF, they worked as an Assistant Investigator at the Joslin Diabetes Center from July 1999 to August 2003. Mark also worked as an Instructor at Harvard Medical School from 2002 to 2003.

Mark Anderson attended Northwestern University from 1983 to 1987, where they received a B.A. in Biological Sciences. Mark then enrolled at The University of Chicago Pritzker School of Medicine from 1987 to 1994, earning an M.D. and Ph.D. in Immunology. Following that, they pursued an Internal Medicine Residency Program at the University of Minnesota Hospital and Clinics from 1994 to 1998. Finally, from 1998 to 2001, they specialized in Adult Endocrinology at Massachusetts General Hospital.